Company Overview and News

 
Whitehaven focuses on ramping up approvals for new coal mine

2018-10-16 theage.com.au
Whitehaven Coal remains bullish on its cleaner thermal coal and bringing new coal mines online as its production levels tumble for the quarter.
WHC

 
Whitehaven focuses on ramping up approvals for new coal mine

2018-10-16 watoday.com.au
Whitehaven Coal remains bullish on its cleaner thermal coal and bringing new coal mines online as its production levels tumble for the quarter.
WHC

 
Whitehaven focuses on ramping up approvals for new coal mine

2018-10-16 smh.com.au
Whitehaven Coal remains bullish on its cleaner thermal coal and bringing new coal mines online as its production levels tumble for the quarter.
WHC

 
Asian, UK investors may beat Aussie backers for major coal listing

2018-10-15 watoday.com.au
Miner Coronado Coal is seeking backers for the world’s largest mining listing since 2011, but Australian investors may have lost the race to global rivals.
WHC

 
Asian, UK investors may beat Aussie backers for major coal listing

2018-10-15 theage.com.au
Miner Coronado Coal is seeking backers for the world’s largest mining listing since 2011, but Australian investors may have lost the race to global rivals.
WHC

 
Asian, UK investors may beat Aussie backers for major coal listing

2018-10-15 smh.com.au
Miner Coronado Coal is seeking backers for the world’s largest mining listing since 2011, but Australian investors may have lost the race to global rivals.
WHC

 
Executive pay punishment looms at Telstra AGM

2018-10-12 theage.com.au
A tough year already for Telstra chief executive Andy Penn is likely to get even worse on Tuesday. Penn and his embattled executive team will then face irate investors in Sydney at what is shaping as the ugliest annual general meeting since the AMP bloodfest in May.
NAUBF TPGTF NAB NASXF TPPTY TPM NABZY OGFGF WHC OGFGY ORG

 
Executive pay punishment looms at Telstra AGM

2018-10-12 watoday.com.au
A tough year already for Telstra chief executive Andy Penn is likely to get even worse on Tuesday. Penn and his embattled executive team will then face irate investors in Sydney at what is shaping as the ugliest annual general meeting since the AMP bloodfest in May.
NAUBF TPGTF NAB NASXF TPPTY TPM NABZY OGFGF WHC OGFGY ORG

 
Executive pay punishment looms at Telstra AGM

2018-10-12 smh.com.au
A tough year already for Telstra chief executive Andy Penn is likely to get even worse on Tuesday. Penn and his embattled executive team will then face irate investors in Sydney at what is shaping as the ugliest annual general meeting since the AMP bloodfest in May.
NAUBF TPGTF NAB NASXF TPPTY TPM NABZY OGFGF WHC OGFGY ORG

 
Analysts see future for Australian coal miners despite UN warning

2018-10-09 abc.net.au
Analysts see a future for Australian coal miners, despite declining investment in new coal-fired power plants and a global climate change body's report on the dire consequences of global warming.
STAN 580001 STAB STAN STAC 2888 SCBFF WHC

2
Markets Live: ASX closes modestly higher

2018-09-26 watoday.com.au
Australian shares closed marginally higher on Wednesday, as the resource stocks continued to be weighed by the major financials ahead of the royal commission's interim report.
TMP WOPEF RIO BLT RIO SNMYF API SRHYY AGLNF IAG MDBPF OGFGY OISHF AGLNY RTPPF SUN SYR RTNTF ILKAY OSH IAUGY OISHY BHPBF ILKAF SNMCY WPL WHC ILU WOPEY SYAAF MDBKY MPL IAUGF BHP RIO BBL BHP OGFGF WAM BHPLF ORG

2
Financials weigh ASX ahead of Hayne interim report

2018-09-26 watoday.com.au
Australian shares closed marginally higher on Wednesday, as gains in resource stocks were partially offset by the major financials ahead of the royal commission's interim report.
WOPEF RIO BLT RIO SNMYF API AGLNF IAG MDBPF OGFGY OISHF AGLNY RTPPF SUN RTNTF OSH IAUGY OISHY BHPBF SNMCY WPL WHC WOPEY MDBKY MPL IAUGF BHP RIO BBL BHP OGFGF BHPLF ORG

2
Financials weigh ASX ahead of Hayne interim report

2018-09-26 theage.com.au
Australian shares closed marginally higher on Wednesday, as the resource stocks continued to be weighed by the major financials ahead of the royal commission's interim report.
WOPEF RIO BLT RIO SNMYF API AGLNF IAG MDBPF OGFGY OISHF AGLNY RTPPF SUN RTNTF OSH IAUGY OISHY BHPBF SNMCY WPL WHC WOPEY MDBKY MPL IAUGF BHP RIO BBL BHP OGFGF BHPLF ORG

2
Financials weigh ASX ahead of Hayne interim report

2018-09-26 smh.com.au
Australian shares closed marginally higher on Wednesday, as the resource stocks continued to be weighed by the major financials ahead of the royal commission's interim report.
WOPEF RIO BLT RIO SNMYF API AGLNF IAG MDBPF OGFGY OISHF AGLNY RTPPF SUN RTNTF OSH IAUGY OISHY BHPBF SNMCY WPL WHC WOPEY MDBKY MPL IAUGF BHP RIO BBL BHP OGFGF BHPLF ORG

 
UPDATE 3-Coronado kicks off $950 mln IPO, Australia's top coal float in 6 years

2018-09-24 reuters
SYDNEY/MELBOURNE (Reuters) - U.S.-based Coronado Global Resources Inc launched what is set to be Australia’s biggest coal mining float in six years with an IPO that seeks to raise up to A$1.3 billion ($946.1 million) and capitalize on Asian demand for the steelmaking commodity.
YACAF WFAFY WFAFF WHC YAL

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:WHC / WHITEHAVEN COAL LIMITED on message board site Silicon Investor.

Wackenhut Corrections Corp. (WHC) Wackenhut Corrections Corp. (WHC) Wackenhut Corrections Corp. (WHC)